Acucela, Otsuka Pharmaceutical granted FDA Fast Track designation for ACU-4429 in treatment of dry out AMD Acucela Inc., a clinical-stage biotechnology company centered on developing new remedies for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., announced they have received Fast today Monitor designation from the U.S. Food and Drug Administration for ACU-4429, an investigational oral treatment for dry age-related macular degeneration .It really is hard to imagine a clearer exemplory case of how laboratory analysis could make a difference inside our everyday lives, Dr. Hait said. Furthermore to their fine study, their continuing engagement in the general public health debate surrounding the vaccine’s program exemplifies them as technology advocates of the truest kind. Dr. Lowy has received the Wallace Rowe Award for Virus Analysis and is a person in many scientific advisory boards, grants committees, and editorial boards. Schiller offers received the Society for Investigative Dermatology’s Naomi Kanof Clinical Investigator Award and offers served as an advisor to the World Health Business and Gates Basis on HPV vaccine-related matters. The Landon/AACR Prizes in Tumor Research were launched in the summertime of 2002 to market and incentive seminal contributions to our knowledge of cancer through basic and translational cancer study.